Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip D Home, Stuart J Pocock, Henning Beck-Nielsen, Paula S Curtis, Ramon Gomis, Markolf Hanefeld, Nigel P Jones, Michel Komajda, John J V McMurray, RECORD Study Team

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Udgivelsesdato: 2009-Jun-20
OriginalsprogEngelsk
TidsskriftLancet
Vol/bind373
Udgave nummer9681
Sider (fra-til)2125-35
Antal sider10
ISSN0140-6736
DOI
StatusUdgivet - 20. jun. 2009

Fingeraftryk Dyk ned i forskningsemnerne om 'Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater